Recurrent pregnancy loss, defined medically as two or more consecutive pregnancy losses before twenty weeks of gestation, affects approximately one to two percent of couples trying to conceive. Despite how isolating it feels, it is not uncommon, and it is not without explanation or treatment. In the majority of cases, a thorough investigation reveals one or more identifiable contributing factors, and with the right clinical approach, most couples who have experienced recurrent loss go on to achieve a successful pregnancy.
This guide explains what causes recurrent pregnancy loss, what investigations are essential, how IVF with preimplantation genetic testing fits into the treatment picture, and how to move forward after multiple losses with both realistic hope and clinical confidence.
What Causes Recurrent Pregnancy Loss
Recurrent pregnancy loss is not a single condition with a single cause. It is a clinical outcome that can result from multiple different underlying factors, and in some couples more than one contributing factor is present simultaneously. A thorough investigative workup is therefore essential before any treatment decisions are made.
Chromosomal abnormalities in the embryo are the most common cause of individual pregnancy losses and play a significant role in recurrent loss as well. When an embryo carries an abnormal number of chromosomes, it typically cannot develop to term. Most aneuploid pregnancies end in miscarriage, often very early in the first trimester. In most cases these chromosomal errors are random events related to egg or sperm quality rather than an inherited condition in either parent. However, in a small proportion of couples with recurrent loss, one partner carries a balanced chromosomal rearrangement that, while causing no health problems for the carrier, significantly increases the probability of chromosomally abnormal embryos.
Uterine structural abnormalities are found in a meaningful proportion of women with recurrent pregnancy loss. A uterine septum, which is a band of fibrous tissue dividing the uterine cavity, is one of the most common and most surgically correctable uterine causes of recurrent miscarriage. Fibroids that protrude into the uterine cavity, intrauterine adhesions, and in some cases a bicornuate or arcuate uterus can all interfere with implantation and early pregnancy development.
Antiphospholipid syndrome is an autoimmune condition in which the body produces antibodies that promote abnormal blood clotting. In pregnancy, this clotting tendency can impair blood flow through the placenta, disrupting fetal development and causing pregnancy loss. Antiphospholipid syndrome is one of the most important treatable causes of recurrent miscarriage, and it is identified through blood testing for anticardiolipin antibodies, anti-beta2 glycoprotein antibodies, and lupus anticoagulant.
Hormonal abnormalities including thyroid dysfunction, elevated prolactin, poorly controlled diabetes, and luteal phase insufficiency can all contribute to recurrent pregnancy loss. Thyroid autoimmunity in particular has been associated with recurrent miscarriage even in women whose thyroid hormone levels are within the normal range, and treatment with levothyroxine in antibody-positive women has shown benefit in some studies.
Inherited thrombophilias, genetic variants that predispose to abnormal blood clotting, are another area of investigation in recurrent loss, though the evidence for treatment in this context is less clear-cut than for antiphospholipid syndrome.
In a proportion of couples with recurrent pregnancy loss, thorough investigation does not reveal a specific cause. This unexplained recurrent loss is frustrating but does not mean that treatment is impossible. The natural conception success rate even without specific treatment is meaningful in this group, and targeted interventions including IVF with preimplantation genetic testing can meaningfully improve outcomes.
The Essential Investigations After Recurrent Loss
A structured investigative workup is the foundation of appropriate management after recurrent pregnancy loss. The following investigations are considered standard of care in most evidence-based guidelines.
Karyotyping of both partners identifies whether either carries a balanced chromosomal rearrangement. If a balanced translocation or other structural chromosomal variant is identified, genetic counselling is essential to understand the implications for future pregnancies and the potential role of preimplantation genetic testing.
Uterine cavity assessment through hysteroscopy, sonohysterography, or three-dimensional ultrasound evaluates the uterine structure for septums, fibroids, polyps, and adhesions. Hysteroscopy is the gold standard because it provides direct visualisation and allows simultaneous surgical correction of identified abnormalities.
Antiphospholipid antibody testing should be conducted on two occasions at least twelve weeks apart to confirm the diagnosis of antiphospholipid syndrome, as a single positive result may represent a transient finding rather than a persistent autoimmune condition.
Thyroid function testing including TSH measurement and thyroid antibody screening identifies both overt and subclinical thyroid dysfunction as well as autoimmune thyroid disease.
If available and appropriate, genetic testing of the pregnancy tissue from a previous loss can provide valuable information about whether chromosomal abnormality was the cause of that specific loss. This information helps direct subsequent investigation and treatment planning.
Where IVF Fits Into Recurrent Pregnancy Loss Management
IVF is not the first intervention for every couple with recurrent pregnancy loss. For couples who conceive naturally but repeatedly miscarry, the primary goal is to identify and treat the underlying cause of loss rather than to assist conception itself. Many couples with recurrent loss conceive without difficulty and do not need IVF to achieve pregnancy.
However, IVF with preimplantation genetic testing for aneuploidy, known as PGT-A, occupies an important and increasingly well-supported role in the management of recurrent pregnancy loss, particularly in couples where chromosomal abnormalities in embryos are believed to be a significant contributing factor.
PGT-A involves the biopsy of embryos at the blastocyst stage followed by comprehensive chromosomal analysis before transfer. By identifying which embryos are chromosomally normal before they are transferred, PGT-A removes the single largest contributor to pregnancy loss from the equation. Only euploid embryos, those with a normal complement of chromosomes, are transferred, which significantly reduces the probability of miscarriage in the subsequent pregnancy.
Studies evaluating PGT-A in couples with recurrent pregnancy loss have found meaningful reductions in miscarriage rates and improvements in live birth rates per transfer compared to transferring untested embryos. The benefit is most pronounced in older patients and in those where previous pregnancy loss tissue testing has confirmed chromosomal abnormality as a contributing factor.
IVF with PGT-A is also the treatment of choice for couples where one partner carries a balanced chromosomal translocation. In these cases, a high proportion of naturally conceived embryos will carry an unbalanced chromosomal complement that leads to miscarriage or abnormal development. PGT-A, or more specifically preimplantation genetic testing for structural rearrangements, allows the identification and selective transfer of only those embryos with a balanced or normal chromosomal complement, dramatically reducing the probability of pregnancy loss.
Managing Treatment for Antiphospholipid Syndrome
For couples where antiphospholipid syndrome has been identified as a contributing cause of recurrent pregnancy loss, treatment with low-dose aspirin and low molecular weight heparin during pregnancy has strong evidence supporting its use. This combination therapy reduces the clotting tendency that impairs placental blood flow and has been shown to significantly improve live birth rates in affected women compared to no treatment.
Treatment is typically begun as soon as pregnancy is confirmed and continued throughout the pregnancy with close obstetric monitoring. For women with antiphospholipid syndrome pursuing IVF, anticoagulation therapy is usually initiated around the time of embryo transfer and continued if a positive pregnancy test is obtained.
The Emotional Dimension of Recurrent Loss
No clinical guide to recurrent pregnancy loss is complete without honest acknowledgment of the profound emotional impact of this experience. Each miscarriage is a loss, and the cumulative grief of multiple losses can be overwhelming. Many couples describe feelings of guilt, anger, fear, and a deep sense of injustice that is difficult to process without support.
Psychological support is not a supplementary consideration in recurrent pregnancy loss. It is a clinical necessity. Research has found that couples who receive psychological support during investigation and treatment for recurrent loss have better emotional outcomes and in some studies better pregnancy outcomes than those who do not. Access to a therapist or counsellor with experience in reproductive loss should be considered as fundamental a part of care as the investigative workup itself.
Connecting with a compassionate and experienced IVF Center in Jaipur that treats recurrent pregnancy loss with the clinical seriousness and emotional sensitivity it deserves gives couples the integrated support they need to move through this experience with both medical precision and genuine human care.
Moving Forward After Recurrent Loss
The statistics for couples who pursue thorough investigation and targeted treatment after recurrent pregnancy loss are genuinely encouraging. Research suggests that even after three or more pregnancy losses, the majority of couples who receive appropriate investigation and treatment go on to achieve a successful pregnancy.
The path forward requires patience, a willingness to engage with a thorough investigative process, and trust in a medical team that takes your history seriously and designs your care around the specific factors identified in your case. It also requires acknowledging that moving forward does not mean forgetting the pregnancies that were lost. Grief and hope can coexist, and both are part of this journey.
For expert fertility care that combines comprehensive investigation, evidence-based treatment, and genuine compassion for the emotional complexity of recurrent pregnancy loss, a trusted test tube baby center in jaipur with experienced reproductive specialists gives your next pregnancy the most carefully prepared and thoroughly supported foundation it can have.
Final Thoughts
Recurrent pregnancy loss is one of the most painful experiences in reproductive medicine, but it is not a sentence of permanent childlessness. It is a clinical problem with identifiable causes in most cases, and those causes have targeted treatments that work.
Investigate thoroughly. Treat what can be treated. Use every available tool including IVF with genetic testing where appropriate. And above all, do not give up on the family you are working toward. The path forward exists, and it is one that many couples before you have walked successfully.